Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_48h.class.cls #double_gel_8d_versus_double_gel_48h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_48h_repos |
Upregulated in class | double_gel_8d |
GeneSet | PASSERINI_INFLAMMATION |
Enrichment Score (ES) | 0.71535105 |
Normalized Enrichment Score (NES) | 1.9422148 |
Nominal p-value | 0.0018115942 |
FDR q-value | 0.0082480945 |
FWER p-Value | 0.419 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | FOS | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 9 | 0.936 | 0.2445 | Yes |
2 | PROCR | PROCR Entrez,  Source | protein C receptor, endothelial (EPCR) | 37 | 0.690 | 0.4232 | Yes |
3 | TNFAIP6 | TNFAIP6 Entrez,  Source | tumor necrosis factor, alpha-induced protein 6 | 116 | 0.483 | 0.5439 | Yes |
4 | CCL2 | CCL2 Entrez,  Source | chemokine (C-C motif) ligand 2 | 145 | 0.452 | 0.6601 | Yes |
5 | IGFBP1 | IGFBP1 Entrez,  Source | insulin-like growth factor binding protein 1 | 584 | 0.209 | 0.6819 | Yes |
6 | NFKBIA | NFKBIA Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 754 | 0.176 | 0.7154 | Yes |
7 | IL8RB | IL8RB Entrez,  Source | interleukin 8 receptor, beta | 2611 | 0.065 | 0.5930 | No |
8 | IL1R1 | IL1R1 Entrez,  Source | interleukin 1 receptor, type I | 3540 | 0.042 | 0.5343 | No |
9 | NFKB1 | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 3740 | 0.038 | 0.5293 | No |
10 | CD97 | CD97 Entrez,  Source | CD97 molecule | 4342 | 0.026 | 0.4911 | No |
11 | ADORA3 | ADORA3 Entrez,  Source | adenosine A3 receptor | 5346 | 0.009 | 0.4182 | No |
12 | DNAJC8 | DNAJC8 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily C, member 8 | 5671 | 0.005 | 0.3951 | No |
13 | CXCR4 | CXCR4 Entrez,  Source | chemokine (C-X-C motif) receptor 4 | 5981 | 0.000 | 0.3720 | No |
14 | AGER | AGER Entrez,  Source | advanced glycosylation end product-specific receptor | 6554 | -0.008 | 0.3313 | No |
15 | IL1A | IL1A Entrez,  Source | interleukin 1, alpha | 7552 | -0.023 | 0.2626 | No |
16 | IKBKAP | IKBKAP Entrez,  Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein | 7916 | -0.029 | 0.2430 | No |
17 | CYBB | CYBB Entrez,  Source | cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 8263 | -0.035 | 0.2262 | No |
18 | CD14 | CD14 Entrez,  Source | CD14 molecule | 8706 | -0.042 | 0.2041 | No |
19 | PTGS2 | PTGS2 Entrez,  Source | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 8937 | -0.046 | 0.1989 | No |
20 | NFKB2 | NFKB2 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 9267 | -0.052 | 0.1879 | No |
21 | CXCL10 | CXCL10 Entrez,  Source | chemokine (C-X-C motif) ligand 10 | 13301 | -0.450 | 0.0031 | No |